Inside story on SA's second Covid-19 vaccine trial: Wits vaccinology Professor Shabir Madhi

Loading player...
University of the Witwatersrand vaccinology expert Professor Shabir Madhi tells BizNews about how US drug company Novavax got to run a critical trial of its coronavirus vaccine. He shares the details of why this is a promising vaccine and picks up on the latest developments on Covid-19 vaccine trials in South Africa. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Aug 2020 4PM English South Africa Investing · Business News

Other recent episodes

How Egoli Youth Empowerment turned squash into a pathway to opportunity for Joburg's youth

Egoli Youth Empowerment started with squash courts in Soweto and grew into a holistic youth development programme spanning sport, academic support, life skills, leadership, entrepreneurship and urban farming. Director Glenn Lazarus and Programme Director Sharon Sibanda tell BizNews how EYE is creating safe spaces, developing young talent, and helping vulnerable…
15 May 9AM 19 min

Fighting to save South Africa’s moral compass: Unashamedly Ethical's Gary Power

Gary Power lifts the lid on corruption, ethical collapse, and the fight to rebuild South Africa from the ground up. In this powerful conversation, the CEO of Unashamedly Ethical shares how his father transformed a major construction business, why integrity is a survival strategy, and how collective action, faith, and…
14 May 6AM 28 min